General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-24 | 2024-03 | 3.45 | 3.67 | 0.22 | 6.38% |
2024-02-13 | 2023-12 | 3.16 | 2.95 | -0.21 | -6.65% |
2023-11-08 | 2023-09 | 3.99 | 4.36 | 0.37 | 9.27% |
2023-07-25 | 2023-06 | 3.77 | 4.02 | 0.25 | 6.63% |
2023-04-25 | 2023-03 | 3.25 | 3.4 | 0.15 | 4.62% |
2023-02-15 | 2022-12 | 3.51 | 4.05 | 0.54 | 15.38% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-09-05 | HSBC | Upgrade | Buy | |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-08-28 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-13 | Mizuho | Upgrade | Buy | Buy |
2023-08-07 | Atlantic Equities | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-15 | ALEXANDER SUSAN H | Officer | 51.68K | Conversion of Exercise of derivative security |
2023-06-25 | DORSA CAROLINE D | Director | 24.82K | Stock Award(Grant) |
2024-02-15 | GREGORY GINGER | Officer | 13.58K | Conversion of Exercise of derivative security |
2023-06-25 | HAWKINS WILLIAM A III | Director | 5.15K | Stock Award(Grant) |
2024-02-15 | IZZAR RACHID | Officer | 9.70K | Conversion of Exercise of derivative security |
2024-02-15 | KRAMER ROBIN C | Officer | 6.23K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Primecap Management Company | 16.03M | 4.56B | 11.07% |
2023-06-29 | Blackrock Inc. | 14.07M | 4.01B | 9.71% |
2023-06-29 | Vanguard Group Inc | 12.20M | 3.47B | 8.42% |
2023-06-29 | State Street Corporation | 6.89M | 1.96B | 4.75% |
2023-06-29 | Wellington Management Group, LLP | 5.35M | 1.52B | 3.69% |
2023-06-29 | JP Morgan Chase & Company | 4.47M | 1.27B | 3.09% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard/Primecap Fund | 9.00M | 2.56B | 6.21% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.56M | 1.23B | 3.15% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 4.51M | 1.28B | 3.11% |
2023-06-29 | Vanguard 500 Index Fund | 3.45M | 981.68M | 2.38% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 2.45M | 655.85M | 1.69% |
2023-06-29 | Vanguard Horizon Fund-Capital Opportunity Fund | 2.18M | 621.04M | 1.51% |
Split | Date |
---|---|
3 : 1 | 2001-01-18 |
2 : 1 | 1999-12-21 |
This stock will final with - 3%
Quick to sell .. it will continually drop..
Sell as much as possible,. Now is the time
Good time to sell now... it will drop soon
$BIIB the trials has been looked at by other PhDs and scientists.. it most likely wont get approval. Needs more trials
No bounce today. Will stay around 279-284. Killings options
All day this think will move around 279-283
$BIIB wtf is this thing doing
$BIIB hoping to see $260 the drug doesn’t look promising at all
I Read the details on this drug.
How in the world did this stock pop like this with that info???
For sure it’s manipulation
Up after hours
$BIIB just die already lol